Japan Mental Health Market Report 2026-2034
According to the latest report by IMARC Group, the Japan mental health market size reached USD 27.5 Billion in 2025. Looking forward, the market is projected to reach USD 37.6 Billion by 2034, exhibiting a CAGR of 3.6% during 2026-2034.
Market Size & Outlook
- Market Size (2025): USD 27.5 Billion
- Forecast Value (2034): USD 37.6 Billion
- Growth Rate (2026-2034): 3.6% CAGR
Request a Business Sample Report for Procurement & Investment Evaluation:Â https://www.imarcgroup.com/japan-mental-health-market/requestsample
Japan Mental Health Market Trends & Drivers
Japan’s mental health sector is expanding as social awareness grows and the stigma historically attached to psychiatric care progressively fades across the country. A rising number of people are seeking help for stress, anxiety, and depression as a direct result of public awareness campaigns and workplace education programs, and this shift is being reinforced by growing integration of mental health services into schools, corporate HR structures, and mainstream healthcare delivery. Japan’s deeply rooted overwork culture continues to generate significant demand for treatment, with occupational stress related mental health claims reaching record levels in recent years and pushing companies to expand employee assistance programs and preventive wellness initiatives.
Regulatory momentum is reinforcing this growth trajectory, with mandatory workplace stress check requirements for larger employers now well established and national health insurance coverage gradually expanding to include approved digital therapeutics. Destigmatization efforts and expanding student access to digital mental health applications are normalizing early help seeking behavior among younger demographics, while Japan’s rapidly aging population is simultaneously driving demand for geriatric mental health services addressing dementia, late life depression, and loneliness related anxiety. Together, these forces are positioning mental health as an increasingly mainstream component of Japan’s broader healthcare system rather than a peripheral specialty.
Japan Mental Health Market Growth Drivers
Key factors supporting the expansion of the Japan mental health market include:
- Rapidly aging population driving demand for geriatric and dementia related mental health services
- Escalating workplace stress and burnout sustaining demand for outpatient and digital services
- Government policy reforms and mandatory workplace stress check programs
- Growing insurance coverage for digital therapeutics and telemedicine consultations
- Expanding destigmatization efforts increasing early treatment seeking behavior
- Rising integration of AI diagnostics and digital mental health platforms across care delivery
Japan Mental Health Market Government Support & Regulatory Landscape
Japan’s regulatory framework is actively fostering mental health sector growth through digital and AI enabled care pathways, with practitioners required to adopt tele-mental health tools from April 2025 and multiple software based digital therapeutics receiving formal regulatory approval. Since 2015, mandatory annual Stress Check surveys have been required for companies with more than 50 employees, enabling earlier risk detection and driving sustained demand for outpatient counselling and employee assistance programs across corporate Japan.
National health insurance coverage has expanded to include approved digital therapeutics products, alongside ongoing revisions to telemedicine reimbursement rates that are reducing financial barriers and increasing outpatient and digital mental health service uptake across income groups. The government has also pursued formal public private partnerships focused on digital dementia care tools, reflecting a broader policy commitment to embedding mental health support into community and home care settings as Japan’s population continues to age.
Impact of AI on the Japan Mental Health Market
- AI-Powered Diagnostics and Screening:Â AI diagnostic tools operating under Japan’s Unified AI Guidelines are expanding across clinical settings, with platforms like Ubie already integrated across roughly 1,700 medical facilities, supporting faster and more consistent mental health screening.
- Digital Therapeutics and VR-Based Treatment:Â Pharmaceutical companies are developing AI and VR powered digital therapeutics targeting social anxiety disorder, generalized anxiety disorder, and major depressive disorder, expanding Japan’s pharmacological-digital hybrid treatment pipeline.
- Remote Monitoring for Geriatric Care:Â AI enabled monitoring systems using smartphone applications, location tags, and camera based safety tools are extending dementia care and mental health monitoring into community and home care settings for Japan’s aging population.
Japan Mental Health Market Opportunities
Japan’s mental health sector presents significant opportunity in digital therapeutics and teletherapy platforms, an area benefiting from expanding insurance reimbursement and growing regulatory approval of software based treatment products. Corporate wellness and employee assistance program services represent another substantial growth avenue, as companies increasingly treat psychological risk management as a core HR responsibility rather than an optional benefit.
Geriatric mental health services, particularly dementia monitoring and remote care technology, offer a durable long term opportunity given Japan’s demographic trajectory, while pediatric mental health programs addressing anxiety, depression, and ADHD in schools represent an emerging segment supported by growing government focus on early intervention. Companies able to combine culturally appropriate care models with digital delivery infrastructure are well positioned to capture demand across Japan’s expanding mental health care ecosystem.
Japan Mental Health Market Industry Segmentation
Disorder Insights:
- Depression and Anxiety
- Schizophrenia
- Alcohol Use Disorder
- Bipolar Disorder
- Post-traumatic Stress Disorder
- Substance Abuse Disorder
- Eating Disorder
- Others
Service Insights:
- Outpatient Counselling
- Emergency Mental Health Services
- Home-based Treatment Services
- Inpatient Hospital Treatment Services
- Others
Age Group Insights:
- Adult
- Pediatric
- Geriatric
Local insights:
- Kanto region
- Kinki region
- Central/Chubu region
- Kyushu-Okinawa region
- Tohoku region
- Chugoku region
- Hokkaido region
- Shikoku region
Competitive Landscape
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
- Otsuka Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Company Limited
- Sumitomo Pharma Co., Ltd.
- Shionogi & Co., Ltd.
- Eisai Co., Ltd.
Recent News and Developments
- April 2025:Â Japan’s regulatory framework began requiring mental health practitioners to adopt tele-mental health tools, alongside formal approval of five software-based digital therapeutic treatments, reflecting the country’s structural shift toward digital and AI-enabled mental health care delivery.
- February 2026:Â Journey Health unveiled a comprehensive 360-degree digital mental health care model designed for both California and Japan, integrating outpatient teletherapy, AI-assisted wellness check-ins, and caregiver support modules targeted specifically at Japan’s aging population and working-adult patient segments.
Future Market Outlook
Japan’s mental health market is positioned for steady, structurally supported growth through 2034, driven by demographic pressures from an aging population, sustained workplace stress and burnout, and continued government policy reform embedding psychological risk management into standard healthcare and corporate practice. Preventive care, early diagnosis, and long term therapy adoption are expected to increase across all age groups as awareness grows and societal stigma continues to decline, while expanding AI diagnostics, digital therapeutics, and telepsychiatry infrastructure will further strengthen access to care across both urban and underserved regional markets.
Why Buy This Report?
- Comprehensive market analysis and long-term forecast through 2034
- Detailed segmentation across disorder, service, and age group
- Competitive landscape and company profiling
- Key market trends, drivers, and investment opportunities
- Strategic recommendations and business intelligence
- Customized analyst support and additional regional analysis available
Note: Have specific requirements not covered here? We offer full customization — just share your needs and we’ll tailor the report accordingly.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
Street: 563-13 Kamien
Country: Tokyo, Japan
Postal Code: 4380111
Email: sales@imarcgroup.com
Source: IMARC Group
